Literature DB >> 10903260

Specific HLA in pulmonary MAC infection in a Japanese population.

M Takahashi1, A Ishizaka, H Nakamura, K Kobayashi, M Nakamura, M Namiki, T Sekita, S Okajima.   

Abstract

Patients with pulmonary Mycobacterium avium complex (MAC) infection occasionally have neither past histories of pulmonary diseases nor underlying immunodeficiency conditions. Therefore, we hypothesized that MAC may be linked with a disease-susceptibility gene and determined human leukocyte-associated antigens (HLA) in patients with pulmonary MAC infection. HLA phenotypes were tested in 59 patients with pulmonary MAC infection, and diagnosed according to the criteria of the American Thoracic Society. Data of a Japanese population reported at the Tenth Japan HLA Workshop were used as a control. HLA-A33 (28.8% versus 12.5%, p = 5 x 10(-)(4)) and HLA-DR6 (50.8% versus 20.2%, p = 5 x 10(-)(8)) antigen frequencies in patients with MAC were significantly increased compared with those of the control population. Frequency of a haplotype A33-B44-DR6 in the MAC patients was also significantly increased compared with those of the control population (23.7% versus 4.2%; p = 3 x 10(-)(9)). These data suggest that development of pulmonary MAC infection is associated with specific HLA in a Japanese population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903260     DOI: 10.1164/ajrccm.162.1.9908071

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

Review 1.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

2.  Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.

Authors:  Jennifer Adjemian; Kenneth N Olivier; Amy E Seitz; Steven M Holland; D Rebecca Prevots
Journal:  Am J Respir Crit Care Med       Date:  2012-02-03       Impact factor: 21.405

3.  Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease.

Authors:  M Ashworth Dirac; Kathleen L Horan; David R Doody; J Scott Meschke; David R Park; Lisa A Jackson; Noel S Weiss; Kevin L Winthrop; Gerard A Cangelosi
Journal:  Am J Respir Crit Care Med       Date:  2012-08-02       Impact factor: 21.405

Review 4.  Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.

Authors:  D Rebecca Prevots; Theodore K Marras
Journal:  Clin Chest Med       Date:  2014-11-06       Impact factor: 2.878

5.  HLA antigens and nontuberculous mycobacterial lung disease in Korean patients.

Authors:  Sang-Won Um; Chang-Seok Ki; O Jung Kwon; Won-Jung Koh
Journal:  Lung       Date:  2009-02-14       Impact factor: 2.584

Review 6.  Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective.

Authors:  Won-Jung Koh; O Jung Kwon; Kyung Soo Lee
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

7.  Mycobacterium avium genotype is associated with the therapeutic response to lung infection.

Authors:  T Kikuchi; Y Kobashi; T Hirano; N Tode; A Santoso; T Tamada; S Fujimura; Y Mitsuhashi; Y Honda; T Nukiwa; M Kaku; A Watanabe; M Ichinose
Journal:  Clin Microbiol Infect       Date:  2013-07-05       Impact factor: 8.067

Review 8.  Pulmonary non-tuberculous mycobacterial infections: current state and future management.

Authors:  Kai Ling Chin; Maria E Sarmiento; Nadine Alvarez-Cabrera; Mohd Nor Norazmi; Armando Acosta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

9.  A case of familial hot tub lung.

Authors:  Yoshihiro Kitahara; Yusuke Araki; Kikuo Nakano
Journal:  Respir Med Case Rep       Date:  2016-02-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.